KR20110002459A - 치료 화합물로서의 치환된 피페리딘 - Google Patents

치료 화합물로서의 치환된 피페리딘 Download PDF

Info

Publication number
KR20110002459A
KR20110002459A KR1020107022007A KR20107022007A KR20110002459A KR 20110002459 A KR20110002459 A KR 20110002459A KR 1020107022007 A KR1020107022007 A KR 1020107022007A KR 20107022007 A KR20107022007 A KR 20107022007A KR 20110002459 A KR20110002459 A KR 20110002459A
Authority
KR
South Korea
Prior art keywords
methoxy
straight
methyl
acid
chain
Prior art date
Application number
KR1020107022007A
Other languages
English (en)
Korean (ko)
Inventor
피터 헤롤드
로버트 마
스테판 스튜츠
빈센조 췬케
알렉산다르 스토야노비치
디르크 벤케
스테판 옐라코비치
Original Assignee
노파르티스 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노파르티스 아게 filed Critical 노파르티스 아게
Publication of KR20110002459A publication Critical patent/KR20110002459A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020107022007A 2008-04-02 2009-04-01 치료 화합물로서의 치환된 피페리딘 KR20110002459A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08153929 2008-04-02
EP08153929.8 2008-04-02

Publications (1)

Publication Number Publication Date
KR20110002459A true KR20110002459A (ko) 2011-01-07

Family

ID=40627638

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107022007A KR20110002459A (ko) 2008-04-02 2009-04-01 치료 화합물로서의 치환된 피페리딘

Country Status (10)

Country Link
EP (1) EP2271644A1 (pt)
JP (1) JP2011516453A (pt)
KR (1) KR20110002459A (pt)
CN (1) CN101970431A (pt)
AU (1) AU2009232012A1 (pt)
BR (1) BRPI0910991A2 (pt)
CA (1) CA2719070A1 (pt)
EA (1) EA201001517A1 (pt)
MX (1) MX2010010876A (pt)
WO (1) WO2009121914A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011057160A2 (en) * 2009-11-06 2011-05-12 The Regents Of The Uiversity Of California Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
CN102638981B (zh) 2009-10-14 2015-07-22 默沙东公司 提高p53活性的取代的哌啶和其用途
GB201008209D0 (en) * 2010-05-17 2010-06-30 Senexis Ltd Compounds
US8987274B2 (en) 2011-10-28 2015-03-24 Merck Sharp & Dohme Corp Macrocycles that increase p53 activity and the uses thereof
TW201429969A (zh) 2012-12-20 2014-08-01 Merck Sharp & Dohme 作爲hdm2抑制劑之經取代咪唑吡啶
CN105001300A (zh) * 2014-04-17 2015-10-28 复旦大学 组织蛋白酶d抑制剂及其制备方法、药物组合物和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1816122A3 (en) * 2006-01-19 2007-09-19 Speedel Experimenta AG 3,4,5-substituted piperidines as therapeutic compounds
EP1911758A1 (en) * 2006-10-04 2008-04-16 Speedel Experimenta AG Phenyl piperidine derivatives for use as renin inhibitors
EP1908761A1 (en) * 2006-10-04 2008-04-09 Speedel Experimenta AG Organic compounds

Also Published As

Publication number Publication date
EA201001517A1 (ru) 2011-04-29
AU2009232012A1 (en) 2009-10-08
CN101970431A (zh) 2011-02-09
BRPI0910991A2 (pt) 2016-01-19
EP2271644A1 (en) 2011-01-12
CA2719070A1 (en) 2009-10-08
MX2010010876A (es) 2010-10-26
WO2009121914A1 (en) 2009-10-08
JP2011516453A (ja) 2011-05-26

Similar Documents

Publication Publication Date Title
US20070167433A1 (en) 3,4,5-Substituted piperidines as therapeutic compounds
US8153658B2 (en) Piperidine derivative or salt thereof
JP5872552B2 (ja) 化学化合物
US20070066582A1 (en) Diaminoalcohols as therapeutic compounds
KR20110002459A (ko) 치료 화합물로서의 치환된 피페리딘
JP6609306B2 (ja) 6,7−ジヒドロピラゾロ[1,5−a]ピラジン−4(5H)−オン化合物およびMGLUR2受容体の負のアロステリック調節因子としてのその使用
US20070021413A1 (en) Diamino alcohols as therapeutic compounds
PT2841437T (pt) Derivados de imidazotiadiazol e imidazopirazina como inibidores de recetor 4 ativado por protease (par4) para o tratamento de agregação plaquetária
JP2017533253A (ja) アルツハイマー病を治療するための、bace1阻害剤としての2−アミノ−3,5−ジフルオロ−3,6−ジメチル−6−フェニル−3,4,5,6−テトラヒドロピリジン
TW200302726A (en) Nitrogen-containing bicyclic compound and medicament containing same as active ingredient
TW201443064A (zh) 經雜芳基取代之六氫哌喃並[3,4-d][1,3]噻□-2-胺化合物
AU2021333558B2 (en) Inhibitors of SARM1
EP1958666A1 (en) Heterocyclic-substituted alkanamides as therapeutic compounds
CA3123215A1 (en) Inhibitors of sarm1 in combination with neuroprotective agents
KR102420210B1 (ko) 치환된 바이사이클릭 디하이드로피리미디논 및 호중구 엘라스타제 활성 억제제로서의 이의 용도
US20070021400A1 (en) Amino alcohols as therapeutic compounds
WO2009106599A2 (en) Substituted piperidines as therapeutic compounds
ES2519572T3 (es) Moduladores del receptor de tipo toll y usos de los mismos
TW201111375A (en) N-substituted cyclic amino derivative
EP1867329A2 (en) 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamides as therapeutic compounds
JP2018529647A (ja) 2−アミノ−3,5,5−トリフルオロ−3,4,5,6−テトラヒドロピリジンの投与を含む併用治療
US20070021399A1 (en) Amido-amino alcohols as therapeutic compounds
EP1987834A2 (en) Substituted piperidines as therapeutic compounds
US20070066604A1 (en) Diaminoalcohols as therapeutic compounds
EP4259619A1 (en) Benzopyrazole inhibitors of sarm1

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination